Wikipedia

User:IntentionallyDense/sandbox3

< User:IntentionallyDense
(Redirected from User:CursedWithTheAbilityToDoTheMath/sandbox3)
Vasculitis
Other namesVasculitides[1]
Petechia and purpura on the lower limb due to infection-associated vasculitis.
Pronunciation

Vasculitis refers to the inflammation and destruction of blood vessels. Vasculitides are an uncommon and diverse group of disorders.[2]

Signs and symptoms

edit

The clinical presentation of the various vasculitides on the skin and internal organs is mostly determined by the diameter or size of the vessels mainly affected.[3] Non-specific symptoms are common and include fever, headache, fatigue, myalgia, weight loss, and arthralgia.[4][5]

All forms of vasculitis, even large vessel vasculitides, may cause skin manifestations. The most common skin manifestations include purpura, nodules, livedo reticularis, skin ulcers, and purpuric urticaria.[6]

Type Name Main symptoms
Primary large vessel vasculitis[7] Takayasu arteritis Diminished or absent pulses, vascular bruits, hypertension, Takayasu retinopathy, and aortic regurgitation.[8]
Giant cell arteritis Headache, scalp tenderness, jaw claudication, and blindness.[9]
Primary medium vessel vasculitis[7] Polyarteritis nodosa Mononeuritis multiplex, nodules, purpura, livedo, and hypertension.[10]
Kawasaki disease Fever, conjunctivitis, exanthema, palmoplantar erythema, cervical lymphadenopathy, and mucosal enanthema.[11][12]
Primary small vessel antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis[7] Microscopic polyangiitis Focal segmental rapidly progressive glomerulonephritis, proteinuria, hemoptysis, palpable purpura, abdominal pain, and peripheral neuropathy.[13]
Granulomatosis with polyangiitis Crusting rhinorrhea, sinusitis, chronic otitis

media, nasal obstruction, shortness of breath, and chronic cough.[14][15]

Eosinophilic granulomatosis with polyangiitis Asthma, allergic rhinitis, sinusitis, nasal polyps, peripheral neuropathy, pulmonary infiltrates, and abdominal pain.[16][17]
Primary immune complex small vessel vasculitis[7] Anti-glomerular basement membrane disease Glomerulonephritis, lung hemorrhage, hematuria, hemoptysis, cough, and dyspnea.[18]
Cryoglobulinemic vasculitis Palpable purpura, Raynaud's phenomenon, joint pain,[19] and peripheral neuropathy.
IgA vasculitis Palpable purpura, arthralgia, abdominal pain, nephritis, and haematuria.[20]
Hypocomplementemic urticarial vasculitis Hives, arthralgia, membranoproliferative glomerulonephritis, and chronic obstructive pulmonary disease.[21]
Primary variable vessel vasculitis[7] Behcet’s disease Oral ulcers, genital ulcers, papulopustular lesions, uveitis, superficial venous thrombosis and deep vein thrombosis.[22]
Cogan’s syndrome Interstitial keratitis, ocular redness, vertigo, and tinnitus.[23]
Single-organ vasculitis[24][7] Cutaneous small-vessel vasculitis Palpable purpura, necrosis, ulceration, bullae, and nodules.[25]
Cutaneous arteritis Nodules, livedo reticularis, ulcers, and gangrene.[26]
Primary central nervous system vasculitis Headache, cognitive impairment, stroke, encephalopathy, and seizures.[27]
Retinal vasculitis Visual impairments, floaters, and macular edema.[28]
Secondary vasculitis[7] Lupus vasculitis Palpable purpura, petechiae, papulonodular lesions, urticaria lesions, and mononeuritis multiplex.[29]
Rheumatoid vasculitis Purpura, focal digital lesions, ulcers, digital necrosis, pyoderma, distal sensory or motor neuropathy, and mononeuritis multiplex.[30]


Causes

edit

Risk factors

edit

Triggers

edit

Genetics

edit

Virology

edit

Mechanism

edit

Diagnosis

edit

Treatment

edit

Outlook

edit

Epidemiology

edit
Type Age Sex Ethnic differences Incidence Prevalence
Takayasu arteritis 25 ± 12.5[31] 88.3% female, 11.6 % male[31] More common in Southeast Asia[32] Annual 0.4 - 3.4 per million[32] 8.4 - 40 per million[32]
Giant cell arteritis 71-80 years[33] Female to male ratio of 3:1[33] More common in Caucasians.[34] Annual 15–35 per 100 000 individuals 50< years[34] 84 - 250 per 100,000[32]
Polyarteritis nodosa 40–60 years[32] male-to-female ratio of 1.5:1[32] None[32] Annual incidence of 0.9–8.0 per million[32] 31 per million[32]
Kawasaki disease <5 years[32] Male to female ratio of 1.5:1[35] More common in Japan[32] 5 - 22 per 100,000 children < 5 years old in North America, Europe, and Australia. > 50 per 100,000 children < 5 years old in Japan, South Korea and Taiwan.[36]
Microscopic polyangiitis 66.98 ±13.12[37] No difference.[37] More common in Southern Europe.[38] 2.4 per million (Turkey) - 16 per million (USA).[38] 19.3 per million (Turkey) - 184 per million (USA).[38]
Granulomatosis with polyangiitis 55–69 years old.[39] Incidence higher in men.[39] Incidence is higher amongst white people.[39] 11.8/million person-years.[39] 134.9 per million.[39]
Eosinophilic granulomatosis with polyangiitis 57.4±14.2[40] 1.2 per 1,000,000 person-years.[40] 2.0–38.0 per 1,000,000 people.[40]
Anti-glomerular basement membrane disease
Cryoglobulinemic vasculitis
IgA vasculitis <16 years[32]
Hypocomplementemic urticarial vasculitis 40–60 years[32]
Behcet’s disease More common during the second and third decades[32]
Cogan’s syndrome
Cutaneous small-vessel vasculitis
Cutaneous arteritis
Primary central nervous system vasculitis
Retinal vasculitis
Lupus vasculitis
Rheumatoid vasculitis

History

edit

Society and culture

edit

Special populations

edit

Geriatrics

edit

Pregnancy

edit

Children

edit

See also

edit

References

edit
  1. ^ "Vasculitis — Definition". Merriam-Webster Online Dictionary. Archived from the original on 2016-07-01. Retrieved 2009-01-08.
  2. ^ Micheletti, Robert G.; Merkel, Peter A. (2022). "Vasculitis". Interdisciplinary Approaches to Overlap Disorders in Dermatology & Rheumatology. Cham: Springer International Publishing. p. 179–198. doi:10.1007/978-3-319-18446-3_8. ISBN 978-3-319-18445-6.
  3. ^ Sunderkötter, Cord (2022). "Vasculitis and Vasculopathies". Braun-Falco´s Dermatology. Berlin, Heidelberg: Springer Berlin Heidelberg. p. 1125–1169. doi:10.1007/978-3-662-63709-8_64. ISBN 978-3-662-63708-1.
  4. ^ Luqmani, Raashid; Robson, Joanna; Suppiah, Ravi (August 2018). "272: Vasculitis". In Davey, Patrick; Sprigings, David (eds.). Diagnosis and Treatment in Internal Medicine. Oxford University Press. pp. 927–931. ISBN 978-0-19-956874-1. Retrieved 8 August 2024.
  5. ^ Jayne, David (2009). "The diagnosis of vasculitis". Best Practice & Research Clinical Rheumatology. 23 (3): 445–453. doi:10.1016/j.berh.2009.03.001.
  6. ^ Shavit, Eran; Alavi, Afsaneh; Sibbald, R. Gary (2018). "Vasculitis—What Do We Have to Know? A Review of Literature". The International Journal of Lower Extremity Wounds. 17 (4): 218–226. doi:10.1177/1534734618804982. ISSN 1534-7346.
  7. ^ a b c d e f g Jennette, J. Charles (27 September 2013). "Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides". Clinical and Experimental Nephrology. 17 (5). Springer Science and Business Media LLC: 603–606. doi:10.1007/s10157-013-0869-6. ISSN 1342-1751. PMC 4029362. PMID 24072416.
  8. ^ Johnston, S L; Lock, R J; Gompels, M M (2024-03-14). "Takayasu arteritis: a review". Journal of Clinical Pathology. 55 (7). BMJ Publishing Group. doi:10.1136/jcp.55.7.481. PMID 12101189. Retrieved 2024-08-18.
  9. ^ Hoffman, Gary S. (2016-11-01). "Giant Cell Arteritis". Annals of Internal Medicine. 165 (9): ITC67. doi:10.7326/AITC201611010. ISSN 0003-4819.
  10. ^ Forbess, Lindsy; Bannykh, Serguei (2015). "Polyarteritis Nodosa". Rheumatic Disease Clinics of North America. 41 (1): 33–46. doi:10.1016/j.rdc.2014.09.005.
  11. ^ Son, M. B. F.; Newburger, J. W. (2013-04-01). "Kawasaki Disease". Pediatrics in Review. 34 (4): 151–162. doi:10.1542/pir.34-4-151. ISSN 0191-9601.
  12. ^ Hedrich, Christian M.; Schnabel, Anja; Hospach, Toni (2018-07-10). "Kawasaki Disease". Frontiers in Pediatrics. 6. doi:10.3389/fped.2018.00198. ISSN 2296-2360. PMC 6048561. PMID 30042935.
  13. ^ Chung, Sharon A.; Seo, Philip (2010). "Microscopic Polyangiitis". Rheumatic Disease Clinics of North America. 36 (3): 545–558. doi:10.1016/j.rdc.2010.04.003. PMC 2917831. PMID 20688249.
  14. ^ Comarmond, Cloé; Cacoub, Patrice (2014). "Granulomatosis with polyangiitis (Wegener): Clinical aspects and treatment". Autoimmunity Reviews. 13 (11): 1121–1125. doi:10.1016/j.autrev.2014.08.017.
  15. ^ Grygiel-Górniak, Bogna; Limphaibool, Nattakarn; Perkowska, Katarzyna; Puszczewicz, Mariusz (2018-10-03). "Clinical manifestations of granulomatosis with polyangiitis: key considerations and major features". Postgraduate Medicine. 130 (7): 581–596. doi:10.1080/00325481.2018.1503920. ISSN 0032-5481.
  16. ^ Vaglio, A.; Buzio, C.; Zwerina, J. (2013). "Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): state of the art". Allergy. 68 (3): 261–273. doi:10.1111/all.12088. ISSN 0105-4538.
  17. ^ White, Jpe; Dubey, S. (2023). "Eosinophilic granulomatosis with polyangiitis: A review". Autoimmunity Reviews. 22 (1): 103219. doi:10.1016/j.autrev.2022.103219.
  18. ^ Bharati, Joyita; Jhaveri, Kenar D.; Salama, Alan D.; Oni, Louise (2024). "Anti–Glomerular Basement Membrane Disease: Recent Updates". Advances in Kidney Disease and Health. 31 (3): 206–215. doi:10.1053/j.akdh.2024.04.007.
  19. ^ Silva, Filipa; Pinto, Claudemira; Barbosa, Arsénio; Borges, Tiago; Dias, Carlos; Almeida, Jorge (2019). "New insights in cryoglobulinemic vasculitis". Journal of Autoimmunity. 105: 102313. doi:10.1016/j.jaut.2019.102313.
  20. ^ Pillebout, Evangéline; Sunderkötter, Cord (2021). "IgA vasculitis". Seminars in Immunopathology. 43 (5): 729–738. doi:10.1007/s00281-021-00874-9. ISSN 1863-2297.
  21. ^ Gu, Stephanie L.; Jorizzo, Joseph L. (2021). "Urticarial vasculitis". International Journal of Women's Dermatology. 7 (3): 290–297. doi:10.1016/j.ijwd.2021.01.021. PMC 8243153. PMID 34222586.
  22. ^ Bettiol, Alessandra; Prisco, Domenico; Emmi, Giacomo (2020-05-01). "Behçet: the syndrome". Rheumatology. 59 (Supplement_3): iii101–iii107. doi:10.1093/rheumatology/kez626. ISSN 1462-0324.
  23. ^ Iliescu, Daniela Adriana; Timaru, Cristina Mihaela; Batras, Mehdi; Simone, Algerino De; Stefan, Cornel (2024-03-14). "COGAN'S SYNDROME". Romanian Journal of Ophthalmology. 59 (1). Romanian Society of Ophthalmology. PMID 27373108. Retrieved 2024-08-19.
  24. ^ Martins-Martinho, Joana; Dourado, Eduardo; Khmelinskii, Nikita; Espinosa, Pablo; Ponte, Cristina (2021). "Localized Forms of Vasculitis". Current Rheumatology Reports. 23 (7). doi:10.1007/s11926-021-01012-y. ISSN 1523-3774. PMC 8247627. PMID 34196889.
  25. ^ Russell, James P.; Gibson, Lawrence E. (2006). "Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment". International Journal of Dermatology. 45 (1): 3–13. doi:10.1111/j.1365-4632.2005.02898.x. ISSN 0011-9059.
  26. ^ Furukawa, Fukumi (2012). "Cutaneous Polyarteritis Nodosa: An Update". Annals of Vascular Diseases. 5 (3). Editorial Committee of Annals of Vascular Diseases. doi:10.3400/avd.ra.12.00061. PMID 23555526. Retrieved 2024-08-19.
  27. ^ Junek, Mats; Perera, Kanjana S; Kiczek, Matthew; Hajj-Ali, Rula A (2023-08-26). "Current and future advances in practice: a practical approach to the diagnosis and management of primary central nervous system vasculitis". Rheumatology Advances in Practice. 7 (3). doi:10.1093/rap/rkad080. ISSN 2514-1775. PMC 10712448. PMID 38091383.
  28. ^ Abu El-Asrar, Ahmed M.; Herbort, Carl P.; Tabbara, Khalid F. (2005). "Retinal Vasculitis". Ocular Immunology and Inflammation. 13 (6): 415–433. doi:10.1080/09273940591003828. ISSN 0927-3948.
  29. ^ Leone, Patrizia; Prete, Marcella; Malerba, Eleonora; Bray, Antonella; Susca, Nicola; Ingravallo, Giuseppe; Racanelli, Vito (2021-11-05). "Lupus Vasculitis: An Overview". Biomedicines. 9 (11). MDPI AG: 1626. doi:10.3390/biomedicines9111626. ISSN 2227-9059.
  30. ^ Bartels, Christie M.; Bridges, Alan J. (2010-09-15). "Rheumatoid Vasculitis: Vanishing Menace or Target for New Treatments?". Current Rheumatology Reports. 12 (6). Springer Science and Business Media LLC: 414–419. doi:10.1007/s11926-010-0130-1. ISSN 1523-3774.
  31. ^ a b Alnabwani, Dina; Patel, Palak; Kata, Priyaranjan; Patel, Vraj; Okere, Arthur; Cheriyath, Pramil (2021-09-15). "The Epidemiology and Clinical Manifestations of Takayasu Arteritis: A Descriptive Study of Case Reports". Cureus. Springer Science and Business Media LLC. doi:10.7759/cureus.17998. ISSN 2168-8184.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  32. ^ a b c d e f g h i j k l m n Watts, Richard A.; Hatemi, Gulen; Burns, Jane C.; Mohammad, Aladdin J. (2021-12-01). "Global epidemiology of vasculitis". Nature Reviews Rheumatology. 18 (1). Springer Science and Business Media LLC: 22–34. doi:10.1038/s41584-021-00718-8. ISSN 1759-4790.
  33. ^ a b Sharma, Ankita; Mohammad, Aladdin J.; Turesson, Carl (2020). "Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review". Seminars in Arthritis and Rheumatism. 50 (5). Elsevier BV: 1040–1048. doi:10.1016/j.semarthrit.2020.07.005. ISSN 0049-0172.
  34. ^ a b Watts, Richard A.; Scott, David G.I. (2014). "Epidemiology of vasculitis". Oxford Textbook of Vasculitis. Oxford University Press. p. 6–25. doi:10.1093/med/9780199659869.003.0002. ISBN 978-0-19-965986-9.
  35. ^ Rowley, Anne H.; Shulman, Stanford T. (2018-12-11). "The Epidemiology and Pathogenesis of Kawasaki Disease". Frontiers in Pediatrics. 6. doi:10.3389/fped.2018.00374. ISSN 2296-2360. PMC 6298241. PMID 30619784.
  36. ^ Elakabawi, Karim; Lin, Jing; Jiao, Fuyong; Guo, Ning; Yuan, Zuyi (2020). "Kawasaki Disease: Global Burden and Genetic Background". Cardiology Research. 11 (1). Elmer Press, Inc.: 9–14. doi:10.14740/cr993. ISSN 1923-2829.
  37. ^ a b Bataille, Pierre M.; Durel, Cécile-Audrey; Chauveau, Dominique; Panes, Arnaud; Thervet, Éric Simon; Terrier, Benjamin (2022). "Epidemiology of granulomatosis with polyangiitis and microscopic polyangiitis in adults in France". Journal of Autoimmunity. 133. Elsevier BV: 102910. doi:10.1016/j.jaut.2022.102910. ISSN 0896-8411.
  38. ^ a b c Mohammad, Aladdin J (2020-05-01). "An update on the epidemiology of ANCA-associated vasculitis". Rheumatology. 59 (Supplement_3): iii42–iii50. doi:10.1093/rheumatology/keaa089. ISSN 1462-0324.
  39. ^ a b c d e Pearce, Fiona A.; Grainge, Matthew J.; Lanyon, Peter C.; Watts, Richard A.; Hubbard, Richard B. (2016-12-24). "The incidence, prevalence and mortality of granulomatosis with polyangiitis in the UK Clinical Practice Research Datalink". Rheumatology: kew413. doi:10.1093/rheumatology/kew413. ISSN 1462-0324.
  40. ^ a b c Hwee, Jeremiah; Harper, Lorraine; Fu, Qinggong; Nirantharakumar, Krishnarajah; Mu, George; Jakes, Rupert W. (2024). "Prevalence, incidence and healthcare burden of eosinophilic granulomatosis with polyangiitis in the UK". ERJ Open Research. 10 (3): 00430–2023. doi:10.1183/23120541.00430-2023. ISSN 2312-0541. PMC 11089387. PMID 38746859.

Further reading

edit
edit
Retrieved from "https://en.wikipedia.org/w/index.php?title=User:IntentionallyDense/sandbox3&oldid=1245045601"